Experimental AI tool predicts which COVID-19 patients develop respiratory disease

An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found. The work was led by NYU Grossman School of Medicine and the Courant Institute of Mathematical Sciences at New York University, in partnership with Wenzhou Central Hospital and Cangnan People's Hospital, both in Wenzhou, China.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news